2003
DOI: 10.1093/jnci/95.4.291
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Deguelin on the Phosphatidylinositol 3-Kinase/Akt Pathway and Apoptosis in Premalignant Human Bronchial Epithelial Cells

Abstract: The ability of deguelin to inhibit PI3K/Akt-mediated signaling pathways may contribute to the potency and specificity of this pro-apoptotic drug. Because both premalignant and malignant HBE cells are more sensitive to deguelin than normal HBE cells, deguelin may have potential as both a chemopreventive agent for early stages of lung carcinogenesis and a therapeutic agent against lung cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

17
219
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 246 publications
(236 citation statements)
references
References 38 publications
17
219
0
Order By: Relevance
“…7 In addition, deguelin was suggested to be useful for chemoprevention and the induction of apoptosis in lung carcinogenesis and for therapy in confirmed lung cancer. [8][9][10][11][12] It was shown that the pro-apoptotic activity of deguelin in premalignant and malignant bronchial epithelial cells was caused by the inhibition of phosphoinositide-3 kinase (PI3K) activity and the reduction of Akt phosphorylation. 12 Furthermore, Bortul et al 13 described that deguelin might be used in the future for increasing sensitivity to therapeutic treatments of leukemic cells with an active PI3K/Akt signaling network.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…7 In addition, deguelin was suggested to be useful for chemoprevention and the induction of apoptosis in lung carcinogenesis and for therapy in confirmed lung cancer. [8][9][10][11][12] It was shown that the pro-apoptotic activity of deguelin in premalignant and malignant bronchial epithelial cells was caused by the inhibition of phosphoinositide-3 kinase (PI3K) activity and the reduction of Akt phosphorylation. 12 Furthermore, Bortul et al 13 described that deguelin might be used in the future for increasing sensitivity to therapeutic treatments of leukemic cells with an active PI3K/Akt signaling network.…”
Section: Introductionmentioning
confidence: 99%
“…[8][9][10][11][12] It was shown that the pro-apoptotic activity of deguelin in premalignant and malignant bronchial epithelial cells was caused by the inhibition of phosphoinositide-3 kinase (PI3K) activity and the reduction of Akt phosphorylation. 12 Furthermore, Bortul et al 13 described that deguelin might be used in the future for increasing sensitivity to therapeutic treatments of leukemic cells with an active PI3K/Akt signaling network. Because activated Akt can affect numerous cellular functions via intermediary molecules, including mTOR, NF-kB and p53, which control cell survival, growth and proliferation, effective inhibition of PI3K/Akt by deguelin means it can affect the activation of NF-kB.…”
Section: Introductionmentioning
confidence: 99%
“…Clear evidence shows that the PI3K/Akt signalling pathway is involved in lung carcinogenesis (Brognard et al, 2001;Chun et al, 2003;Lee et al, 2003;Tsao et al, 2003;Massion et al, 2004). Akt is frequently activated in both premalignant human bronchial epithelial cells and NSCLC cells.…”
mentioning
confidence: 99%
“…This finding was confirmed by caspase activity assay. Many well-known phytochemicals that can safely modulate physiological function and enhance anti-cancer activity induce apoptosis through mitochondrial pathway (Chun et al, 2003;Gupta et al, 2013). Similarly, FEOJ induced apoptosis through induction of loss of MMP (ΔΨm).…”
Section: Discussionmentioning
confidence: 99%